D3A.023
Benign carcinoid tumor of the transverse colon
Clinical Classification Guidelines
Medical Intelligence & Overview
A benign carcinoid tumor of the transverse colon is a non-cancerous growth that develops in the cells of the neuroendocrine system within the transverse colon, which is a part of the large intestine. Although labeled as benign, meaning it is not malignant or cancerous, it requires medical attention and monitoring to ensure it does not lead to complications or develop into a malignant form over time.
Causes & Symptoms
Clinical Causes: Genetic factors that influence cell growth Inherited syndromes associated with neuroendocrine tumors Previous radiation exposure in the abdominal region Chronic inflammatory conditions of the colon Unknown for many cases, as exact causes are not clearly established
Key Symptoms: Often asymptomatic, especially in early stages Abdominal pain or discomfort Changes in bowel habits, such as diarrhea or constipation Unexplained weight loss in some cases Occasional bleeding or anemia if the tumor causes mucosal irritation Palpable mass in the abdomen in larger tumors
Diagnostic & Treatment
Diagnosis Path: Diagnosing a benign carcinoid tumor of the transverse colon involves several procedures to confirm its presence and assess its characteristics:
Treatment Protocols: Management of a benign carcinoid tumor generally involves a combination of medical procedures aimed at removing the tumor and preventing potential complications:
Clinical Advice & FAQs
Billing Guidance
Is D3A.023 a billable ICD-10 code?
Yes, D3A.023 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D3A.023?
Clinical documentation must specify the nature of Benign carcinoid tumor of the transverse colon and any associated comorbidities for accurate reporting.
Cite this Clinical Reference